{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,8]],"date-time":"2026-09-08T23:45:54Z","timestamp":1788911154615,"version":"build-2803163510"},"reference-count":103,"publisher":"Elsevier BV","issue":"1","license":[{"start":{"date-parts":[[2026,1,1]],"date-time":"2026-01-01T00:00:00Z","timestamp":1767225600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,1,1]],"date-time":"2026-01-01T00:00:00Z","timestamp":1767225600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2025,9,26]],"date-time":"2025-09-26T00:00:00Z","timestamp":1758844800000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100000272","name":"National Institute for Health and Care Research","doi-asserted-by":"publisher","award":["ACF-2024-02-010"],"award-info":[{"award-number":["ACF-2024-02-010"]}],"id":[{"id":"10.13039\/501100000272","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100018955","name":"Leeds Biomedical Research Centre","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100018955","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","em-consulte.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Joint Bone Spine"],"published-print":{"date-parts":[[2026,1]]},"DOI":"10.1016\/j.jbspin.2025.105981","type":"journal-article","created":{"date-parts":[[2025,9,27]],"date-time":"2025-09-27T21:32:35Z","timestamp":1759008755000},"page":"105981","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":4,"title":["Current understanding of the challenges in the diagnosis and management of spondyloarthritis in older adults"],"prefix":"10.1016","volume":"93","author":[{"ORCID":"https:\/\/orcid.org\/0009-0006-3737-557X","authenticated-orcid":false,"given":"Jacob Corum","family":"Williams","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-9683-3407","authenticated-orcid":false,"given":"Helena","family":"Marzo-Ortega","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.jbspin.2025.105981_bib0520","series-title":"StatPearls","article-title":"Seronegative spondyloarthropathy","author":"Sen","year":"2025"},{"key":"10.1016\/j.jbspin.2025.105981_bib0525","doi-asserted-by":"crossref","first-page":"1620","DOI":"10.1093\/rheumatology\/keaa807","article-title":"Diagnostic delay in axial spondyloarthritis: a systematic review and meta-analysis","volume":"60","author":"Zhao","year":"2021","journal-title":"Rheumatol Oxf Engl"},{"key":"10.1016\/j.jbspin.2025.105981_bib0530","doi-asserted-by":"crossref","first-page":"keaf226","DOI":"10.1093\/rheumatology\/keaf226","article-title":"What is the economic burden of delayed axial spondyloarthritis diagnosis in the UK?","volume":"64","author":"Zanghelini","year":"2025","journal-title":"Rheumatology"},{"key":"10.1016\/j.jbspin.2025.105981_bib0535","doi-asserted-by":"crossref","first-page":"752","DOI":"10.1016\/S0140-6736(12)62167-9","article-title":"Frailty in elderly people","volume":"381","author":"Clegg","year":"2013","journal-title":"Lancet"},{"key":"10.1016\/j.jbspin.2025.105981_bib0540","doi-asserted-by":"crossref","first-page":"1878","DOI":"10.1002\/art.41741","article-title":"The epidemiology of psoriatic arthritis over 5 decades: a population-based study","volume":"73","author":"Karmacharya","year":"2021","journal-title":"Arthritis Rheumatol Hoboken NJ"},{"key":"10.1016\/j.jbspin.2025.105981_bib0545","doi-asserted-by":"crossref","first-page":"901","DOI":"10.1093\/geront\/gnv130","article-title":"Lifespan and healthspan: past, present, and promise","volume":"55","author":"Crimmins","year":"2015","journal-title":"Gerontologist"},{"key":"10.1016\/j.jbspin.2025.105981_bib0550","doi-asserted-by":"crossref","first-page":"1008","DOI":"10.3899\/jrheum.111082","article-title":"Clinical features of late-onset ankylosing spondylitis: comparison with early-onset disease","volume":"39","author":"Montilla","year":"2012","journal-title":"J Rheumatol"},{"key":"10.1016\/j.jbspin.2025.105981_bib0555","doi-asserted-by":"crossref","first-page":"1468","DOI":"10.1093\/rheumatology\/keab544","article-title":"Age at onset in axial spondyloarthritis around the world: data from the assessment in SpondyloArthritis International Society peripheral involvement in spondyloarthritis study","volume":"61","author":"Boel","year":"2021","journal-title":"Rheumatol Oxf Engl"},{"key":"10.1016\/j.jbspin.2025.105981_bib0560","doi-asserted-by":"crossref","first-page":"49","DOI":"10.1007\/s10067-023-06799-y","article-title":"Prevalence of axial spondyloarthritis in Colombia: data from the National Health Registry 2017-2021","volume":"43","author":"Barahona-Correa","year":"2024","journal-title":"Clin Rheumatol"},{"key":"10.1016\/j.jbspin.2025.105981_bib0565","doi-asserted-by":"crossref","first-page":"77","DOI":"10.1177\/2040622317743486","article-title":"New advances in the understanding and treatment of axial spondyloarthritis: from chance to choice","volume":"9","author":"Dubash","year":"2018","journal-title":"Ther Adv Chronic Dis"},{"key":"10.1016\/j.jbspin.2025.105981_bib0570","doi-asserted-by":"crossref","first-page":"3242","DOI":"10.1093\/rheumatology\/keaf089","article-title":"The 2025 British Society for Rheumatology guideline for the treatment of axial spondyloarthritis with biologic and targeted synthetic DMARDs","volume":"64","author":"Zhao","year":"2025","journal-title":"Rheumatology"},{"key":"10.1016\/j.jbspin.2025.105981_bib0575","doi-asserted-by":"crossref","first-page":"iv1","DOI":"10.1093\/rheumatology\/keaa437","article-title":"Axial spondyloarthritis: coming of age","volume":"59","author":"Marzo-Ortega","year":"2020","journal-title":"Rheumatol Oxf Engl"},{"key":"10.1016\/j.jbspin.2025.105981_bib0580","doi-asserted-by":"crossref","first-page":"576","DOI":"10.1038\/s41574-018-0059-4","article-title":"Inflammaging: a new immune\u00a0\u2013\u00a0metabolic viewpoint for age-related diseases","volume":"14","author":"Franceschi","year":"2018","journal-title":"Nat Rev Endocrinol"},{"key":"10.1016\/j.jbspin.2025.105981_bib0585","doi-asserted-by":"crossref","first-page":"505","DOI":"10.1038\/s41569-018-0064-2","article-title":"Inflammageing: chronic inflammation in ageing, cardiovascular disease, and frailty","volume":"15","author":"Ferrucci","year":"2018","journal-title":"Nat Rev Cardiol"},{"key":"10.1016\/j.jbspin.2025.105981_bib0590","doi-asserted-by":"crossref","first-page":"748","DOI":"10.1136\/annrheumdis-2014-206119","article-title":"Premature senescence of T-cell subsets in axial spondyloarthritis","volume":"75","author":"Fessler","year":"2016","journal-title":"Ann Rheum Dis"},{"key":"10.1016\/j.jbspin.2025.105981_bib0595","doi-asserted-by":"crossref","first-page":"R292","DOI":"10.1186\/ar793","article-title":"Prevalence, clinical relevance and characterization of circulating cytotoxic CD4+CD28-T cells in ankylosing spondylitis","volume":"5","author":"Duftner","year":"2003","journal-title":"Arthritis Res Ther"},{"key":"10.1016\/j.jbspin.2025.105981_bib0600","doi-asserted-by":"crossref","first-page":"297","DOI":"10.1007\/s00296-009-0949-9","article-title":"Altered T-cell subtypes in spondyloarthritis, rheumatoid arthritis and polymyalgia rheumatica","volume":"30","author":"Dejaco","year":"2010","journal-title":"Rheumatol Int"},{"key":"10.1016\/j.jbspin.2025.105981_bib0605","doi-asserted-by":"crossref","first-page":"854","DOI":"10.1002\/art.43109","article-title":"An Immunosenescent CD8+ T Cell Subset in patients with axial spondyloarthritis and psoriatic arthritis links spontaneous motility to telomere shortening and dysfunction","volume":"77","author":"Paldino","year":"2025","journal-title":"Arthritis Rheumatol Hoboken Nj"},{"key":"10.1016\/j.jbspin.2025.105981_bib0610","doi-asserted-by":"crossref","DOI":"10.1177\/1759720X241271886","article-title":"Metabolic syndrome and psoriatic arthritis: the role of weight loss as a disease-modifying therapy","volume":"16","author":"Williams","year":"2024","journal-title":"Ther Adv Musculoskelet Dis"},{"key":"10.1016\/j.jbspin.2025.105981_bib0615","first-page":"351","article-title":"Effect of age at disease onset in the clinical profile of spondyloarthritis: a study of 1424 Brazilian patients","volume":"30","author":"Skare","year":"2012","journal-title":"Clin Exp Rheumatol"},{"key":"10.1016\/j.jbspin.2025.105981_bib0620","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1186\/s13075-024-03339-0","article-title":"Epidemiological trends in psoriatic arthritis: a comprehensive population-based study","volume":"26","author":"Haddad","year":"2024","journal-title":"Arthritis Res Ther"},{"key":"10.1016\/j.jbspin.2025.105981_bib0625","doi-asserted-by":"crossref","first-page":"42","DOI":"10.5455\/medarh.2015.69.42-45","article-title":"Modes of presentation of reactive arthritis based on the affected joints","volume":"69","author":"Lahu","year":"2015","journal-title":"Med Arch"},{"key":"10.1016\/j.jbspin.2025.105981_bib0630","doi-asserted-by":"crossref","first-page":"631408","DOI":"10.1155\/2013\/631408","article-title":"Enteropathic spondyloarthritis: from diagnosis to treatment","volume":"2013","author":"Peluso","year":"2013","journal-title":"Clin Dev Immunol"},{"key":"10.1016\/j.jbspin.2025.105981_bib0635","doi-asserted-by":"crossref","first-page":"266","DOI":"10.4103\/injr.injr_208_22","article-title":"Identifying clinical features, frailty, and treatment responses of late-onset axial spondyloarthritis","volume":"18","author":"Bayrak","year":"2023","journal-title":"Indian J Rheumatol"},{"key":"10.1016\/j.jbspin.2025.105981_bib0640","doi-asserted-by":"crossref","first-page":"2829","DOI":"10.1007\/s10067-025-07462-4","article-title":"Gender, clinical phenotype and imaging features of patients with late-onset psoriatic arthritis","volume":"44","author":"Wang","year":"2025","journal-title":"Clin Rheumatol"},{"key":"10.1016\/j.jbspin.2025.105981_bib0645","doi-asserted-by":"crossref","first-page":"e14431","DOI":"10.1097\/MD.0000000000014431","article-title":"Characteristics of late-onset spondyloarthritis in Japan","volume":"98","author":"Endo","year":"2019","journal-title":"Medicine (Baltimore)"},{"key":"10.1016\/j.jbspin.2025.105981_bib0650","doi-asserted-by":"crossref","first-page":"523","DOI":"10.2165\/11315970-000000000-00000","article-title":"Late-onset ankylosing spondylitis and spondylarthritis","volume":"27","author":"Toussirot","year":"2010","journal-title":"Drugs Aging"},{"key":"10.1016\/j.jbspin.2025.105981_bib0655","first-page":"1214","article-title":"Late onset peripheral spondyloarthropathy","volume":"16","author":"Dubost","year":"1989","journal-title":"J Rheumatol"},{"key":"10.1016\/j.jbspin.2025.105981_bib0660","first-page":"899","article-title":"Late onset undifferentiated seronegative spondyloarthropathy","volume":"22","author":"Olivieri","year":"1995","journal-title":"J Rheumatol"},{"key":"10.1016\/j.jbspin.2025.105981_bib0665","doi-asserted-by":"crossref","first-page":"927","DOI":"10.1007\/s00296-007-0331-8","article-title":"Late onset undifferentiated spondyloarthritis presenting with polymyalgia rheumatica features: description of seven cases","volume":"27","author":"Olivieri","year":"2007","journal-title":"Rheumatol Int"},{"key":"10.1016\/j.jbspin.2025.105981_bib0670","first-page":"1837","article-title":"Comparison of extracapsular changes by magnetic resonance imaging in patients with rheumatoid arthritis and polymyalgia rheumatica","volume":"28","author":"McGonagle","year":"2001","journal-title":"J Rheumatol"},{"key":"10.1016\/j.jbspin.2025.105981_bib0675","doi-asserted-by":"crossref","first-page":"3496","DOI":"10.1002\/art.22942","article-title":"Evidence for a different anatomic basis for joint disease localization in polymyalgia rheumatica in comparison with rheumatoid arthritis","volume":"56","author":"Marzo-Ortega","year":"2007","journal-title":"Arthritis Rheum"},{"key":"10.1016\/j.jbspin.2025.105981_bib0680","doi-asserted-by":"crossref","first-page":"398","DOI":"10.7861\/clinmedicine.13-4-398","article-title":"Polymyalgia rheumatica: pathogenesis and management","volume":"13","author":"Mackie","year":"2013","journal-title":"Clin Med"},{"key":"10.1016\/j.jbspin.2025.105981_bib0685","first-page":"404","article-title":"RS3PE revisited: a systematic review and meta-analysis of 331 cases","volume":"34","author":"Karmacharya","year":"2016","journal-title":"Clin Exp Rheumatol"},{"key":"10.1016\/j.jbspin.2025.105981_bib0690","doi-asserted-by":"crossref","first-page":"451","DOI":"10.2165\/00002512-200522060-00001","article-title":"Late-onset ankylosing spondylitis and related spondylarthropathies","volume":"22","author":"Toussirot","year":"2005","journal-title":"Drugs Aging"},{"key":"10.1016\/j.jbspin.2025.105981_bib0695","doi-asserted-by":"crossref","first-page":"422","DOI":"10.5114\/reum.2022.123672","article-title":"Paraneoplastic arthritides: an up-to-date case-based systematic review","volume":"60","author":"Al Khayyat","year":"2022","journal-title":"Reumatologia"},{"key":"10.1016\/j.jbspin.2025.105981_bib0700","first-page":"676","article-title":"Recognition and management of polymyalgia rheumatica and giant cell arteritis","volume":"88","author":"Caylor","year":"2013","journal-title":"Am Fam Physician"},{"key":"10.1016\/j.jbspin.2025.105981_bib0705","series-title":"StatPearls","article-title":"Diffuse idiopathic skeletal hyperostosis","author":"Luo","year":"2025"},{"key":"10.1016\/j.jbspin.2025.105981_bib0710","doi-asserted-by":"crossref","first-page":"101527","DOI":"10.1016\/j.berh.2020.101527","article-title":"Diffuse idiopathic skeletal hyperostosis: etiology and clinical relevance","volume":"34","author":"Kuperus","year":"2020","journal-title":"Best Pract Res Clin Rheumatol"},{"key":"10.1016\/j.jbspin.2025.105981_bib0715","doi-asserted-by":"crossref","first-page":"145","DOI":"10.1002\/acr.23244","article-title":"Imaging findings suggestive of axial spondyloarthritis in diffuse idiopathic skeletal hyperostosis","volume":"70","author":"Latourte","year":"2018","journal-title":"Arthritis Care Res"},{"key":"10.1016\/j.jbspin.2025.105981_bib0720","doi-asserted-by":"crossref","first-page":"147","DOI":"10.1186\/s13075-024-03359-w","article-title":"Significant overlap of inflammatory and degenerative features on imaging among patients with degenerative disc disease, diffuse idiopathic skeletal hyperostosis and axial spondyloarthritis: a real-life cohort study","volume":"26","author":"Ziade","year":"2024","journal-title":"Arthritis Res Ther"},{"key":"10.1016\/j.jbspin.2025.105981_bib0725","doi-asserted-by":"crossref","first-page":"352","DOI":"10.1186\/1471-2474-14-352","article-title":"The prevalence of moderate to severe radiographic sacroiliitis and the correlation with health status in elderly Swedish men--the MrOS study","volume":"14","author":"Exarchou","year":"2013","journal-title":"BMC Musculoskelet Disord"},{"key":"10.1016\/j.jbspin.2025.105981_bib0730","doi-asserted-by":"crossref","first-page":"1955","DOI":"10.1093\/rheumatology\/kez172","article-title":"Performance of magnetic resonance imaging in the diagnosis of axial spondyloarthritis: a systematic literature review","volume":"58","author":"Jones","year":"2019","journal-title":"Rheumatol Oxf Engl"},{"key":"10.1016\/j.jbspin.2025.105981_bib0735","doi-asserted-by":"crossref","first-page":"915","DOI":"10.3899\/jrheum.170904","article-title":"Age- and sex-dependent frequency of fat metaplasia and other structural changes of the sacroiliac joints in patients without axial spondyloarthritis: a retrospective, cross-sectional MRI Study","volume":"45","author":"Ziegeler","year":"2018","journal-title":"J Rheumatol"},{"key":"10.1016\/j.jbspin.2025.105981_bib0740","first-page":"170","article-title":"OP0243 Prevalence of inflammatory and chronic changes suggestive of axial spondyloarthritis in magnetic resonance images of the axial skeleton in individuals <45 years in the general population as part of a large community study (SHIP)","volume":"77","author":"Baraliakos","year":"2018","journal-title":"Ann Rheum Dis"},{"key":"10.1016\/j.jbspin.2025.105981_bib0745","doi-asserted-by":"crossref","first-page":"1721","DOI":"10.1136\/ard.2008.097931","article-title":"Baseline and 1-year magnetic resonance imaging of the sacroiliac joint and lumbar spine in very early inflammatory back pain. Relationship between symptoms, HLA-B27 and disease extent and persistence","volume":"68","author":"Marzo-Ortega","year":"2009","journal-title":"Ann Rheum Dis"},{"key":"10.1016\/j.jbspin.2025.105981_bib0750","doi-asserted-by":"crossref","first-page":"1055","DOI":"10.1183\/09031936.00059814","article-title":"Ageing and the epidemiology of multimorbidity","volume":"44","author":"Divo","year":"2014","journal-title":"Eur Respir J"},{"key":"10.1016\/j.jbspin.2025.105981_bib0755","doi-asserted-by":"crossref","first-page":"iv47","DOI":"10.1093\/rheumatology\/keaa246","article-title":"Prevalence and impact of comorbidities in axial spondyloarthritis: systematic review and meta-analysis","volume":"59","author":"Zhao","year":"2020","journal-title":"Rheumatol Oxf Engl"},{"key":"10.1016\/j.jbspin.2025.105981_bib0760","doi-asserted-by":"crossref","first-page":"275","DOI":"10.1007\/s00296-020-04775-2","article-title":"Comorbidities in psoriatic arthritis: a systematic review and meta-analysis","volume":"41","author":"Gupta","year":"2021","journal-title":"Rheumatol Int"},{"key":"10.1016\/j.jbspin.2025.105981_bib0765","unstructured":"Kim JH, Choi IA. Cardiovascular morbidity and mortality in patients with spondyloarthritis: a meta-analysis, https:\/\/onlinelibrary.wiley.com\/doi\/10.1111\/1756-185X. 13970 (accessed 22 May 2025)."},{"key":"10.1016\/j.jbspin.2025.105981_bib0770","first-page":"333","article-title":"Real-life data on the comorbidities in spondyloarthritis from our multicenter nationwide registry: BioStar","volume":"38","author":"\u00c7ay","year":"2022","journal-title":"Arch Rheumatol"},{"key":"10.1016\/j.jbspin.2025.105981_bib0775","doi-asserted-by":"crossref","first-page":"300","DOI":"10.1002\/acr2.11388","article-title":"Prevalence of frailty in ankylosing spondylitis, psoriatic arthritis, and rheumatoid arthritis: data from a National Claims Dataset","volume":"4","author":"Lieber","year":"2022","journal-title":"ACR Open Rheumatol"},{"key":"10.1016\/j.jbspin.2025.105981_bib0780","doi-asserted-by":"crossref","first-page":"16","DOI":"10.1093\/ageing\/afy169","article-title":"Sarcopenia: revised European consensus on definition and diagnosis","volume":"48","author":"Cruz-Jentoft","year":"2019","journal-title":"Age Ageing"},{"key":"10.1016\/j.jbspin.2025.105981_bib0785","first-page":"652","article-title":"Sarcopenia as a risk factor for falls in elderly individuals: results from the ilSIRENTE study","volume":"31","author":"Landi","year":"2012","journal-title":"Clin Nutr Edinb Scotl"},{"key":"10.1016\/j.jbspin.2025.105981_bib0790","doi-asserted-by":"crossref","first-page":"72","DOI":"10.1186\/s13075-024-03299-5","article-title":"The prevalence of sarcopenia in spondyloarthritis patients: a meta-analysis","volume":"26","author":"Hu","year":"2024","journal-title":"Arthritis Res Ther"},{"key":"10.1016\/j.jbspin.2025.105981_bib0795","doi-asserted-by":"crossref","first-page":"268","DOI":"10.1186\/s12891-016-1155-z","article-title":"Is there a relation between pre-sarcopenia, sarcopenia, cachexia and osteoporosis in patients with ankylosing spondylitis?","volume":"17","author":"El Maghraoui","year":"2016","journal-title":"BMC Musculoskelet Disord"},{"key":"10.1016\/j.jbspin.2025.105981_bib0800","doi-asserted-by":"crossref","first-page":"1566","DOI":"10.1093\/rheumatology\/kex187","article-title":"Muscle wasting in male TNF-\u03b1 blocker na\u00efve ankylosing spondylitis patients: a comparison of gender differences in body composition","volume":"56","author":"Ib\u00e1\u00f1ez Vodnizza","year":"2017","journal-title":"Rheumatology"},{"key":"10.1016\/j.jbspin.2025.105981_bib0805","doi-asserted-by":"crossref","first-page":"6507692","DOI":"10.1155\/2016\/6507692","article-title":"Reduced appendicular lean body mass, muscle strength, and size of type II muscle fibers in patients with spondyloarthritis versus healthy controls: a cross-sectional study","volume":"2016","author":"R\u00f8ren Nord\u00e9n","year":"2016","journal-title":"Sci World J"},{"key":"10.1016\/j.jbspin.2025.105981_bib0810","doi-asserted-by":"crossref","first-page":"1369","DOI":"10.1093\/gerona\/glw253","article-title":"Extensive type II muscle fiber atrophy in elderly female hip fracture patients","volume":"72","author":"Kramer","year":"2017","journal-title":"J Gerontol Ser A"},{"key":"10.1016\/j.jbspin.2025.105981_bib0815","first-page":"248","article-title":"Balance and falls in axial spondyloarthritis: a cross sectional study","volume":"44","author":"Mewes","year":"2019","journal-title":"Acta Reumatol Port"},{"key":"10.1016\/j.jbspin.2025.105981_bib0820","doi-asserted-by":"crossref","first-page":"979","DOI":"10.1007\/s10067-022-06454-y","article-title":"Effects of biologic and target synthetic disease-modifying anti-rheumatic drugs on sarcopenia in spondyloarthritis and rheumatoid arthritis: a systematic review and meta-analysis","volume":"42","author":"Ben Tekaya","year":"2023","journal-title":"Clin Rheumatol"},{"key":"10.1016\/j.jbspin.2025.105981_bib0825","doi-asserted-by":"crossref","first-page":"3283","DOI":"10.1007\/s11606-021-07241-2","article-title":"Ankylosing spondylitis and the risk of hip fractures: a matched cohort study","volume":"37","author":"Tsur","year":"2022","journal-title":"J Gen Intern Med"},{"key":"10.1016\/j.jbspin.2025.105981_bib0830","doi-asserted-by":"crossref","first-page":"18718","DOI":"10.1038\/s41598-019-55196-6","article-title":"One-year mortality after hip fracture surgery and prognostic factors: a prospective cohort study","volume":"9","author":"Morri","year":"2019","journal-title":"Sci Rep"},{"key":"10.1016\/j.jbspin.2025.105981_bib0835","doi-asserted-by":"crossref","first-page":"e8458","DOI":"10.1097\/MD.0000000000008458","article-title":"The association between ankylosing spondylitis and the risk of any, hip, or vertebral fracture","volume":"96","author":"Zhang","year":"2017","journal-title":"Medicine (Baltimore)"},{"key":"10.1016\/j.jbspin.2025.105981_bib0840","doi-asserted-by":"crossref","first-page":"265","DOI":"10.1002\/acr.25219","article-title":"Incidence rate and factors associated with fractures among medicare beneficiaries with ankylosing spondylitis in the United States","volume":"76","author":"Stovall","year":"2024","journal-title":"Arthritis Care Res"},{"key":"10.1016\/j.jbspin.2025.105981_bib0845","doi-asserted-by":"crossref","first-page":"106325","DOI":"10.1016\/j.phrs.2022.106325","article-title":"TNF inhibitors have a protective role in the risk of dementia in patients with ankylosing spondylitis: results from a nationwide study","volume":"182","author":"Watad","year":"2022","journal-title":"Pharmacol Res"},{"key":"10.1016\/j.jbspin.2025.105981_bib0850","doi-asserted-by":"crossref","first-page":"e0229819","DOI":"10.1371\/journal.pone.0229819","article-title":"Tumor Necrosis Factor (TNF) blocking agents are associated with lower risk for Alzheimer's disease in patients with rheumatoid arthritis and psoriasis","volume":"15","author":"Zhou","year":"2020","journal-title":"Plos One"},{"key":"10.1016\/j.jbspin.2025.105981_bib0855","doi-asserted-by":"crossref","first-page":"570992","DOI":"10.3389\/fnagi.2020.570992","article-title":"Association between psoriasis and dementia: current evidence","volume":"12","author":"Liu","year":"2020","journal-title":"Front Aging Neurosci"},{"key":"10.1016\/j.jbspin.2025.105981_bib0860","doi-asserted-by":"crossref","first-page":"e0210335","DOI":"10.1371\/journal.pone.0210335","article-title":"Relationship between dementia and ankylosing spondylitis: a nationwide, population-based, retrospective longitudinal cohort study","volume":"14","author":"Jang","year":"2019","journal-title":"Plos One"},{"key":"10.1016\/j.jbspin.2025.105981_bib0865","doi-asserted-by":"crossref","DOI":"10.1007\/s00296-024-05740-z","article-title":"A comparison of comorbidities and their risk factors prevalence across rheumatoid arthritis, psoriatic arthritis and axial spondyloarthritis with focus on cardiovascular diseases: data from a single center real-world cohort","author":"Gu\u0142a","year":"2024","journal-title":"Rheumatol Int."},{"key":"10.1016\/j.jbspin.2025.105981_bib0870","doi-asserted-by":"crossref","first-page":"706","DOI":"10.1136\/ard-2024-225531","article-title":"EULAR recommendations for the management of psoriatic arthritis with pharmacological therapies: 2023 update","volume":"83","author":"Gossec","year":"2024","journal-title":"Ann Rheum Dis"},{"key":"10.1016\/j.jbspin.2025.105981_bib0875","doi-asserted-by":"crossref","first-page":"2014","DOI":"10.1111\/bcp.14539","article-title":"Underrepresentation of the elderly in clinical trials, time for action","volume":"86","author":"van Marum","year":"2020","journal-title":"Br J Clin Pharmacol"},{"key":"10.1016\/j.jbspin.2025.105981_bib0880","doi-asserted-by":"crossref","first-page":"143","DOI":"10.14336\/AD.2017.0306","article-title":"A comprehensive review of non-steroidal anti-inflammatory drug use in the elderly","volume":"9","author":"Wongrakpanich","year":"2018","journal-title":"Aging Dis"},{"key":"10.1016\/j.jbspin.2025.105981_bib0885","series-title":"StatPearls","article-title":"Corticosteroid adverse effects","author":"Yasir","year":"2025"},{"key":"10.1016\/j.jbspin.2025.105981_bib0890","doi-asserted-by":"crossref","first-page":"356","DOI":"10.3899\/jrheum.150614","article-title":"Methotrexate efficacy in the tight control in psoriatic arthritis (TICOPA) study","volume":"43","author":"Coates","year":"2016","journal-title":"J Rheumatol"},{"key":"10.1016\/j.jbspin.2025.105981_bib0895","series-title":"StatPearls","article-title":"Methotrexate","author":"Hanoodi","year":"2025"},{"key":"10.1016\/j.jbspin.2025.105981_bib0900","doi-asserted-by":"crossref","first-page":"151952","DOI":"10.1016\/j.semarthrit.2022.151952","article-title":"Clinical features of methotrexate osteopathy in rheumatic musculoskeletal disease: a systematic review","volume":"52","author":"Ruffer","year":"2022","journal-title":"Semin Arthritis Rheum"},{"key":"10.1016\/j.jbspin.2025.105981_bib0905","doi-asserted-by":"crossref","first-page":"4913","DOI":"10.1136\/rmdopen-2023-003827","article-title":"Severe methotrexate toxicity in elderly patients under diuretics","volume":"10","author":"Kumar","year":"2024","journal-title":"RMD Open"},{"key":"10.1016\/j.jbspin.2025.105981_bib0910","doi-asserted-by":"crossref","first-page":"124","DOI":"10.1093\/rheumatology\/keq242","volume":"50","author":"Galloway","year":"2011","journal-title":"Rheumatology"},{"key":"10.1016\/j.jbspin.2025.105981_bib0915","doi-asserted-by":"crossref","first-page":"695","DOI":"10.1093\/rheumatology\/keh562","article-title":"Survival and safety of treatment with infliximab in the elderly population","volume":"44","author":"Chevillotte-Maillard","year":"2005","journal-title":"Rheumatology"},{"key":"10.1016\/j.jbspin.2025.105981_bib0920","doi-asserted-by":"crossref","first-page":"379","DOI":"10.1136\/ard.2005.035287","article-title":"Long term safety of etanercept in elderly subjects with rheumatic diseases","volume":"65","author":"Fleischmann","year":"2006","journal-title":"Ann Rheum Dis"},{"key":"10.1016\/j.jbspin.2025.105981_bib0925","doi-asserted-by":"crossref","first-page":"364","DOI":"10.1007\/s12325-019-01145-8","article-title":"Long-term safety of adalimumab in 29,967 adult patients from global clinical trials across multiple indications: an updated analysis","volume":"37","author":"Burmester","year":"2020","journal-title":"Adv Ther"},{"key":"10.1016\/j.jbspin.2025.105981_bib0930","doi-asserted-by":"crossref","first-page":"87","DOI":"10.1016\/j.jare.2018.09.003","article-title":"Risk of serious infection among patients receiving biologics for chronic inflammatory diseases: usefulness of administrative data","volume":"15","author":"Quartuccio","year":"2019","journal-title":"J Adv Res"},{"key":"10.1016\/j.jbspin.2025.105981_bib0935","doi-asserted-by":"crossref","first-page":"336","DOI":"10.1016\/j.ahj.2008.02.025","article-title":"Tumor necrosis factor-\u03b1 antagonist use and heart failure in elderly patients with rheumatoid arthritis","volume":"156","author":"Setoguchi","year":"2008","journal-title":"Am Heart J"},{"key":"10.1016\/j.jbspin.2025.105981_bib0940","doi-asserted-by":"crossref","first-page":"848","DOI":"10.1111\/ced.14258","article-title":"Real-life efficacy and safety of secukinumab in elderly patients with psoriasis over a 2-year period","volume":"45","author":"Megna","year":"2020","journal-title":"Clin Exp Dermatol"},{"key":"10.1016\/j.jbspin.2025.105981_bib0945","doi-asserted-by":"crossref","first-page":"847","DOI":"10.2147\/CCID.S400520","article-title":"Efficacy and safety of secukinumab in elderly patients with moderate to severe plaque-type psoriasis: post-hoc analysis of the SUPREME Study","volume":"16","author":"Talamonti","year":"2023","journal-title":"Clin Cosmet Investig Dermatol"},{"key":"10.1016\/j.jbspin.2025.105981_bib0950","doi-asserted-by":"crossref","first-page":"135","DOI":"10.1007\/s40266-018-0520-z","article-title":"Efficacy and safety of secukinumab in elderly subjects with moderate to severe plaque psoriasis: a pooled analysis of phase III studies","volume":"35","author":"K\u00f6rber","year":"2018","journal-title":"Drugs Aging"},{"key":"10.1016\/j.jbspin.2025.105981_bib0955","doi-asserted-by":"crossref","DOI":"10.5826\/dpc.1403a166","article-title":"Effectiveness of ixekizumab in elderly patients for the treatment of moderate-to-severe psoriasis: results from a multicenter, retrospective real-life study in the Lazio region","volume":"14","author":"Dattola","year":"2024","journal-title":"Dermatol Pract Concept"},{"key":"10.1016\/j.jbspin.2025.105981_bib0960","first-page":"e152","article-title":"Efficacy and safety of ixekizumab in a group of 16 elderly patients with psoriasis over a 1-year period","volume":"34","author":"Megna","year":"2020","journal-title":"J Eur Acad Dermatol Venereol"},{"key":"10.1016\/j.jbspin.2025.105981_bib0965","doi-asserted-by":"crossref","first-page":"2393376","DOI":"10.1080\/09546634.2024.2393376","article-title":"Efficacy and safety of bimekizumab in elderly patients: real-world multicenter retrospective study\u2013IL PSO (Italian landscape psoriasis)","volume":"35","author":"Orsini","year":"2024","journal-title":"J Dermatol Treat"},{"key":"10.1016\/j.jbspin.2025.105981_bib0970","doi-asserted-by":"crossref","first-page":"2177","DOI":"10.2147\/CCID.S487869","article-title":"Real-world experience of bimekizumab in an elderly patients cohort with plaque-type psoriasis: a 24-week retrospective study","volume":"17","author":"Fratton","year":"2024","journal-title":"Clin Cosmet Investig Dermatol"},{"key":"10.1016\/j.jbspin.2025.105981_bib0975","doi-asserted-by":"crossref","first-page":"974","DOI":"10.1111\/1346-8138.12653","article-title":"Efficacy and safety of ustekinumab treatment in elderly patients with psoriasis","volume":"41","author":"Hayashi","year":"2014","journal-title":"J Dermatol"},{"key":"10.1016\/j.jbspin.2025.105981_bib0980","doi-asserted-by":"crossref","first-page":"561","DOI":"10.1111\/ced.14979","article-title":"Anti-interleukin-23 for psoriasis in elderly patients: guselkumab, risankizumab and tildrakizumab in real-world practice","volume":"47","author":"Ruggiero","year":"2022","journal-title":"Clin Exp Dermatol"},{"key":"10.1016\/j.jbspin.2025.105981_bib0985","doi-asserted-by":"crossref","first-page":"1286251","DOI":"10.3389\/fimmu.2023.1286251","article-title":"The optimal use of tildrakizumab in the elderly via improvement of Treg function and its preventive effect of psoriatic arthritis","volume":"14","author":"Fukasawa","year":"2023","journal-title":"Front Immunol"},{"key":"10.1016\/j.jbspin.2025.105981_bib0990","doi-asserted-by":"crossref","first-page":"293","DOI":"10.1016\/j.clinthera.2025.01.005","article-title":"Comparative safety of JAK inhibitors versus TNF or IL-17 inhibitors for cardiovascular disease and cancer in psoriatic arthritis and axial spondyloarthritis","volume":"47","author":"Zhao","year":"2025","journal-title":"Clin Ther"},{"key":"10.1016\/j.jbspin.2025.105981_bib0995","unstructured":"Janus kinase (JAK) inhibitors: new measures to reduce risks of major cardiovascular events, malignancy, venous thromboembolism, serious infections and increased mortality. GOV.UK, https:\/\/www.gov.uk\/drug-safety-update\/janus-kinase-jak-inhibitors-new-measures-to-reduce-risks-of-major-cardiovascular-events-malignancy-venous-thromboembolism-serious-infections-and-increased-mortality (accessed 30 June 2025)."},{"key":"10.1016\/j.jbspin.2025.105981_bib1000","doi-asserted-by":"crossref","first-page":"319","DOI":"10.1097\/BOR.0000000000000187","article-title":"The intestinal microbiome in spondyloarthritis","volume":"27","author":"Gill","year":"2015","journal-title":"Curr Opin Rheumatol"},{"key":"10.1016\/j.jbspin.2025.105981_bib1005","doi-asserted-by":"crossref","first-page":"1315","DOI":"10.3892\/ol.2017.6368","article-title":"Ankylosing spondylitis and the risk of cancer","volume":"14","author":"Chang","year":"2017","journal-title":"Oncol Lett"},{"key":"10.1016\/j.jbspin.2025.105981_bib1010","doi-asserted-by":"crossref","first-page":"312","DOI":"10.1159\/000345623","article-title":"Efficacy and safety of subcutaneous anti-tumor necrosis factor-alpha agents, etanercept and adalimumab, in elderly patients affected by psoriasis and psoriatic arthritis: an observational long-term study","volume":"225","author":"Esposito","year":"2012","journal-title":"Dermatology"},{"key":"10.1016\/j.jbspin.2025.105981_bib1015","doi-asserted-by":"crossref","first-page":"1797","DOI":"10.1007\/s10067-017-3697-3","article-title":"Elderly psoriatic arthritis patients on TNF-\u03b1 blockers: results of an Italian multicenter study on minimal disease activity and drug discontinuation rate","volume":"36","author":"Costa","year":"2017","journal-title":"Clin Rheumatol"},{"key":"10.1016\/j.jbspin.2025.105981_bib1020","doi-asserted-by":"crossref","first-page":"232","DOI":"10.46497\/ArchRheumatol.2024.10391","article-title":"Biological treatment in elderly and young patients with ankylosing spondylitis: TURKBIO real-life data results","volume":"39","author":"Uslu","year":"2024","journal-title":"Arch Rheumatol"},{"key":"10.1016\/j.jbspin.2025.105981_bib1025","doi-asserted-by":"crossref","first-page":"2174","DOI":"10.1002\/acr.25112","article-title":"Persistence of biologics in the treatment of psoriatic arthritis: data from a large hospital-based longitudinal cohort","volume":"75","author":"Rida","year":"2023","journal-title":"Arthritis Care Res"},{"key":"10.1016\/j.jbspin.2025.105981_bib1030","doi-asserted-by":"crossref","first-page":"685","DOI":"10.1007\/s40266-024-01136-7","article-title":"Real-world drug survival of biologics and targeted synthetic disease-modifying anti-rheumatic drugs among patients with psoriatic arthritis","volume":"41","author":"Rosenberg","year":"2024","journal-title":"Drugs Aging"}],"container-title":["Joint Bone Spine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1297319X25001435?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1297319X25001435?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,1,7]],"date-time":"2026-01-07T15:40:33Z","timestamp":1767800433000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1297319X25001435"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,1]]},"references-count":103,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2026,1]]}},"alternative-id":["S1297319X25001435"],"URL":"https:\/\/doi.org\/10.1016\/j.jbspin.2025.105981","relation":{},"ISSN":["1297-319X"],"issn-type":[{"value":"1297-319X","type":"print"}],"subject":[],"published":{"date-parts":[[2026,1]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Current understanding of the challenges in the diagnosis and management of spondyloarthritis in older adults","name":"articletitle","label":"Article Title"},{"value":"Joint Bone Spine","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jbspin.2025.105981","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2025 The Author(s). Published by Elsevier Masson SAS on behalf of Soci\u00e9t\u00e9 Fran\u00e7aise de Rhumatologie.","name":"copyright","label":"Copyright"}],"article-number":"105981"}}